![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Staff Writers Singapore (AFP) Dec 1, 2020
Hong Kong and Singapore on Tuesday indefinitely delayed a "travel bubble" in a new blow to their hard-hit tourism and aviation industries as the Chinese city battles a coronavirus surge. The arrangement allowing people to travel between the financial hubs without quarantining had been due to launch on November 22, but was postponed for two weeks as Hong Kong saw a sudden spike in cases. The delay was not just a blow to the cities, but also other countries which had been hoping the scheme might be a model to replicate during the pandemic. On Tuesday, both cities announced that the bubble would be further deferred to an unspecified date beyond 2020. The decision was taken "in view of the severity of the epidemic situation in Hong Kong with the number of local cases of unknown sources increasing rapidly," the Hong Kong government said in a statement. Singapore is a major market for Hong Kong's tourism industry with more than 450,000 arrivals from the city-state recorded in 2019, according to the Hong Kong Tourism Board. Hong Kong was among the top 15 visitor sources for Singapore last year, with nearly half a million arrivals, official data showed. Hong Kong on Monday reimposed social distancing measures at some of their strictest levels since the start of the coronavirus pandemic, as daily cases rise sharply. Restrictions on public gatherings were tightened with a maximum of two people allowed to meet, down from four, while non-essential civil servants were asked to work from home.
![]() ![]() Pakistanis join final trials for China-made vaccine Islamabad (AFP) Nov 26, 2020 Thousands of volunteers are flocking to research hospitals across Pakistan to join final-stage clinical trials of a Chinese-made vaccine for the coronavirus. It is the first time Pakistan has participated in such a trial, which comes amid a string of positive vaccine announcements by Western pharmaceutical companies this month. The vaccine is being developed by CanSinoBio and the Beijing Institute of Biotechnology China. "I have volunteered myself for a noble cause that will help humanity," ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |